This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1qvo
From Proteopedia
(New page: 200px<br /> <applet load="1qvo" size="450" color="white" frame="true" align="right" spinBox="true" caption="1qvo, resolution 2.22Å" /> '''STRUCTURES OF HLA-A...) |
|||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
HLA-A*1101 is one of the most common human class I alleles worldwide. An, increased frequency of HLA-A*1101 has been observed in cohorts of female, sex workers from Northern Thailand who are highly exposed to HIV-1 and yet, have remained persistently seronegative. In view of this apparent, association of HLA-A*1101 with resistance to acquisition of HIV-1, infection, and given the importance of eliciting strong CTL responses to, control and eliminate HIV-1, we have determined the crystal structure of, HLA-A*1101 complexed with two immunodominant HIV-1 CTL epitopes: the, nonamer reverse transcriptase(313-321) (AIFQSSMTK) and decamer Nef(73-82), (QVPLRPMTYK) peptides. The structures confirm the presence of primary, anchor residues P2-Ile/-Val and P9-/P10-Lys, and also clearly reveal the, presence of secondary anchor residues P6-Ser for reverse transcriptase and, P7-Met for Nef. The overall backbone conformation of both peptides is, defined as two bulges that are separated by a more buried middle residue., In this study, we discuss how this topology may offer functional, advantages in the selection and presentation of HIV-1 CTL epitopes by, HLA-A*1101. Overall, this structural analysis permits a more accurate, definition of the peptide-binding motif of HLA-A*1101, the, characterization of its antigenic surface, and the correlation of, molecular determinants with resistance to HIV-1 infection. These studies, are relevant for the rational design of HLA-A*1101-restricted CTL epitopes, with improved binding and immunological properties for the development of, HIV-1 vaccines. | HLA-A*1101 is one of the most common human class I alleles worldwide. An, increased frequency of HLA-A*1101 has been observed in cohorts of female, sex workers from Northern Thailand who are highly exposed to HIV-1 and yet, have remained persistently seronegative. In view of this apparent, association of HLA-A*1101 with resistance to acquisition of HIV-1, infection, and given the importance of eliciting strong CTL responses to, control and eliminate HIV-1, we have determined the crystal structure of, HLA-A*1101 complexed with two immunodominant HIV-1 CTL epitopes: the, nonamer reverse transcriptase(313-321) (AIFQSSMTK) and decamer Nef(73-82), (QVPLRPMTYK) peptides. The structures confirm the presence of primary, anchor residues P2-Ile/-Val and P9-/P10-Lys, and also clearly reveal the, presence of secondary anchor residues P6-Ser for reverse transcriptase and, P7-Met for Nef. The overall backbone conformation of both peptides is, defined as two bulges that are separated by a more buried middle residue., In this study, we discuss how this topology may offer functional, advantages in the selection and presentation of HIV-1 CTL epitopes by, HLA-A*1101. Overall, this structural analysis permits a more accurate, definition of the peptide-binding motif of HLA-A*1101, the, characterization of its antigenic surface, and the correlation of, molecular determinants with resistance to HIV-1 infection. These studies, are relevant for the rational design of HLA-A*1101-restricted CTL epitopes, with improved binding and immunological properties for the development of, HIV-1 vaccines. | ||
| + | |||
| + | ==Disease== | ||
| + | Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Ankylosing spondylitis, susceptibility to, 1 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]], Hypoproteinemia, hypercatabolic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=109700 109700]], Stevens-Johnson syndrome, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=142800 142800]] | ||
==About this Structure== | ==About this Structure== | ||
| Line 19: | Line 22: | ||
[[Category: immune system]] | [[Category: immune system]] | ||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:57:00 2007'' |
Revision as of 16:50, 12 November 2007
|
STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
Contents |
Overview
HLA-A*1101 is one of the most common human class I alleles worldwide. An, increased frequency of HLA-A*1101 has been observed in cohorts of female, sex workers from Northern Thailand who are highly exposed to HIV-1 and yet, have remained persistently seronegative. In view of this apparent, association of HLA-A*1101 with resistance to acquisition of HIV-1, infection, and given the importance of eliciting strong CTL responses to, control and eliminate HIV-1, we have determined the crystal structure of, HLA-A*1101 complexed with two immunodominant HIV-1 CTL epitopes: the, nonamer reverse transcriptase(313-321) (AIFQSSMTK) and decamer Nef(73-82), (QVPLRPMTYK) peptides. The structures confirm the presence of primary, anchor residues P2-Ile/-Val and P9-/P10-Lys, and also clearly reveal the, presence of secondary anchor residues P6-Ser for reverse transcriptase and, P7-Met for Nef. The overall backbone conformation of both peptides is, defined as two bulges that are separated by a more buried middle residue., In this study, we discuss how this topology may offer functional, advantages in the selection and presentation of HIV-1 CTL epitopes by, HLA-A*1101. Overall, this structural analysis permits a more accurate, definition of the peptide-binding motif of HLA-A*1101, the, characterization of its antigenic surface, and the correlation of, molecular determinants with resistance to HIV-1 infection. These studies, are relevant for the rational design of HLA-A*1101-restricted CTL epitopes, with improved binding and immunological properties for the development of, HIV-1 vaccines.
Disease
Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142800], Ankylosing spondylitis, susceptibility to, 1 OMIM:[142800], Hypoproteinemia, hypercatabolic OMIM:[109700], Stevens-Johnson syndrome, susceptibility to OMIM:[142800]
About this Structure
1QVO is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue., Li L, Bouvier M, J Immunol. 2004 May 15;172(10):6175-84. PMID:15128805
Page seeded by OCA on Mon Nov 12 18:57:00 2007
